These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33045494)

  • 1. Mental health status of relapsing-remitting multiple sclerosis Italian patients returning to work soon after the easing of lockdown during COVID-19 pandemic: A monocentric experience.
    Zanghì A; D'Amico E; Luca M; Ciaorella M; Basile L; Patti F
    Mult Scler Relat Disord; 2020 Nov; 46():102561. PubMed ID: 33045494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychological status of patients with relapsing-remitting multiple sclerosis during coronavirus disease-2019 outbreak.
    Stojanov A; Malobabic M; Milosevic V; Stojanov J; Vojinovic S; Stanojevic G; Stevic M
    Mult Scler Relat Disord; 2020 Oct; 45():102407. PubMed ID: 32702641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? A case-control study with service and research implications for immunopsychiatry.
    Hao F; Tan W; Jiang L; Zhang L; Zhao X; Zou Y; Hu Y; Luo X; Jiang X; McIntyre RS; Tran B; Sun J; Zhang Z; Ho R; Ho C; Tam W
    Brain Behav Immun; 2020 Jul; 87():100-106. PubMed ID: 32353518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The psychological impact of the COVID-19 pandemic on people with multiple sclerosis.
    Vacaras V; Nistor C; Schiopu AM; Vacaras C; Marin GE; Muresanu DF
    Mult Scler Relat Disord; 2023 Aug; 76():104825. PubMed ID: 37320938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring productivity loss in early relapsing-remitting multiple sclerosis.
    Sainz de la Maza S; Maurino J; Borges M; Martín-Martínez J; Sotoca J; Alonso A; Caminero AB; Borrega L; Sánchez-Menoyo JL; Barrero-Hernández FJ; Calles C; Brieva L; Blasco MR; García-Soto JD; Campo-Amigo MD; Navarro-Cantó L; Agüera E; Garcés M; Carmona O; Gabaldón-Torres L; Forero L; Hervás M; de Alda LR; Gómez-Ballesteros R; Castillo-Triviño T
    Mult Scler Relat Disord; 2022 Feb; 58():103398. PubMed ID: 35216781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Has the COVID-19 Pandemic Changed the Daily Practices and Psychological State of Orthopaedic Residents?
    Castioni D; Galasso O; Rava A; Massè A; Gasparini G; Mercurio M;
    Clin Orthop Relat Res; 2021 Sep; 479(9):1947-1954. PubMed ID: 33780402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic.
    Sparaco M; Miele G; Lavorgna L; Abbadessa G; Bonavita S
    Neurol Sci; 2022 May; 43(5):2935-2942. PubMed ID: 35092543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of quality of life in relapsing-remitting and progressive multiple sclerosis.
    Yalachkov Y; Soydaş D; Bergmann J; Frisch S; Behrens M; Foerch C; Gehrig J
    Mult Scler Relat Disord; 2019 May; 30():33-37. PubMed ID: 30735970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The psychological impact of COVID-19-related lockdown measures among a sample of Italian patients with eating disorders: a preliminary longitudinal study.
    Nisticò V; Bertelli S; Tedesco R; Anselmetti S; Priori A; Gambini O; Demartini B
    Eat Weight Disord; 2021 Dec; 26(8):2771-2777. PubMed ID: 33582970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of and Risk Factors Associated With Mental Health Symptoms Among the General Population in China During the Coronavirus Disease 2019 Pandemic.
    Shi L; Lu ZA; Que JY; Huang XL; Liu L; Ran MS; Gong YM; Yuan K; Yan W; Sun YK; Shi J; Bao YP; Lu L
    JAMA Netw Open; 2020 Jul; 3(7):e2014053. PubMed ID: 32609353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of health anxiety in patients with relapsing remitting multiple sclerosis: Misperception, misattribution and quality of life.
    Hayter AL; Salkovskis PM; Silber E; Morris RG
    Br J Clin Psychol; 2016 Nov; 55(4):371-386. PubMed ID: 26806805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression, anxiety, and fear of COVID-19 in patients with multiple sclerosis in pandemic era: a cross-sectional study.
    Alirezaei M; Eskandarieh S; Sahraian MA; Naser Moghadasi A
    Neurol Sci; 2022 Jan; 43(1):59-66. PubMed ID: 34554334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychological distress in the academic population and its association with socio-demographic and lifestyle characteristics during COVID-19 pandemic lockdown: Results from a large multicenter Italian study.
    Fornili M; Petri D; Berrocal C; Fiorentino G; Ricceri F; Macciotta A; Bruno A; Farinella D; Baccini M; Severi G; Baglietto L
    PLoS One; 2021; 16(3):e0248370. PubMed ID: 33690695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sociodemographic and clinical factors associated with depression, anxiety, and general mental health in people with multiple sclerosis during the COVID-19 pandemic.
    Uhr L; Rice DR; Mateen FJ
    Mult Scler Relat Disord; 2021 Nov; 56():103327. PubMed ID: 34666242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab for relapsing-remitting multiple sclerosis.
    He D; Guo R; Zhang F; Zhang C; Dong S; Zhou H
    Cochrane Database Syst Rev; 2013 Dec; (12):CD009130. PubMed ID: 24310855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive social cognitive treatment (can do treatment) with participation of support partners in persons with relapsing remitting multiple sclerosis: observation of improved self-efficacy, quality of life, anxiety and depression 1 year later.
    Jongen PJ; Heerings M; Ruimschotel R; Hussaarts A; Duyverman L; van der Zande A; Valkenburg-Vissers J; van Droffelaar M; Lemmens W; Donders R; Visser LH
    BMC Res Notes; 2016 Jul; 9():375. PubMed ID: 27473375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fear of relapse, social support, and psychological well-being (depression, anxiety, and stress level) of patients with multiple sclerosis (MS) during the COVID-19 pandemic stage.
    Shaygannejad V; Mirmosayyeb O; Nehzat N; Ghajarzadeh M
    Neurol Sci; 2021 Jul; 42(7):2615-2618. PubMed ID: 33860396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the lockdown on the mental health of the general population during the COVID-19 pandemic in Italy: Results from the COMET collaborative network.
    Fiorillo A; Sampogna G; Giallonardo V; Del Vecchio V; Luciano M; Albert U; Carmassi C; Carrà G; Cirulli F; Dell'Osso B; Nanni MG; Pompili M; Sani G; Tortorella A; Volpe U
    Eur Psychiatry; 2020 Sep; 63(1):e87. PubMed ID: 32981568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
    Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Previous psychopathology predicted severe COVID-19 concern, anxiety, and PTSD symptoms in pregnant women during "lockdown" in Italy.
    Ravaldi C; Ricca V; Wilson A; Homer C; Vannacci A
    Arch Womens Ment Health; 2020 Dec; 23(6):783-786. PubMed ID: 33215247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.